Introduction
The central inhibitory neurotransmitter y-aminobutyric acid (GABA) depolarizes neurones in sympathetic ganglia (De Groat, 1970; Bowery & Brown, 1974) , by increasing C1-conductance (Adams & Brown, 1975) . The neurones in this tissue are closely invested by neuroglial (satellite) cells, which possess a transport system capable of taking up exogenous radioactively-labelled GABA (Bowery & Brown, 1972; Young, Brown, Kelly & Schon, 1973) . The question addressed in the present experiments is whether the effect of exogenous GABA on sympathetic neurones is modified by the activity of the adjacent glial carrier.
The results of our previous experiments are not clear on this point. Bowery & Brown (1974) and Adams & Brown (1975) observed no gross change in the depolarizing action of GABA on omitting Na+ ions from the bathing medium, a procedure that inhibits carrier-mediated uptake of GABA by the glial cells (Bowery & Brown, 1972) , but rather high concentrations of GABA were used in these experiments. On the other hand, Bowery, Brown, Collins, Galvan, Marsh & Yanmini (1976: Figure 10 ) detected an increase in the depolarizing action of very low concentrations (< 10 gM) of GABA in Na+-free solution.
In the present experiments the effect of reducing external [Na+] on the depolarizing action of GABA has been assessed more carefully than hitherto. In addition, another method of reducing glial uptake of GABA, the application of false substrates (0-aminobutyric acid, BABA: Bowery et al., 1976 ) and (±)-nipecotic acid (Krogsgaard-Larsen & Johnston, 1975) has been tested.
Methods
Superior cervical ganglia with their attached pre-and postganglionic nerve trunks were isolated from Wistar rats (230-270 g, either sex) anaesthetized with urethane (1.5 g/kg). Potentials were recorded from desheathed superfused preparations as described by Brown & Marsh (1975) . The superfusion fluid was Krebs-Henseleit solution of composition described previously (Bowery et al., 1976) , gassed with 95% 02 and 5% CO2 and maintained at 250C. In the present experiments ganglia were isolated the day before use and maintained overnight at 40C: by allowing the initial demarcation potential to subside, this gives greater d.c. stability for high-gain recording, without altering the response of the ganglia to agonists or the Figure 1 Depolarizations of an isolated ganglion of the rat produced by 4-min applications of 3 M y-aminobutyric acid (GABA, solid bars), (a) before (i), during (ii) and after (iii) exposure to low [Na+] The following compounds were used: y-aminobutyric acid (4-amino-n-butyric acid, GABA: BDH); P-aminobutyric acid (3-amino-n-butyric acid, BABA: Sigma); and 3-aminopropanesulphonic acid (3-APS: K. & K.). (+-Nipecotic acid was synthesized by C. Cooksey according to the method of Freifelder (1963) . Agonists were superfused over the preparation for 4 min at 30-min intervals, unless otherwise stated. The superfusion rate was -2 ml/minute. Dead time was noted using an air-interface, and exposure times corrected accordingly. Concentrations refer to those in contact with the ganglion. (Figure ic) . This potentiation was fully reversed on restoring Na+ ions (Record iii).
Resaks
In the experiment illustrated in Figure lb , a similar procedure was used except that 1 mM fJ-aminobutyric acid (BABA) was added to inhibit GABA uptake. The response to 3 gM GABA now became equivalent to that of 6 gM GABA in the absence of BABA.
A number of experiments of this type were performed, some using as an additional agonist 3-aminopropanesulphonic acid (3-APS). The results are summarized in Figure 2 . There were consistent and substantial increases in the responses to 3 jIM GABA in low-Na+, BABA and (±)-nipecotic acid solutions, but no corresponding increase in the equivalent-amplitude responses to 3-APS.
The effect of low-Na+ solution on the dose-response curve to GABA is shown in Figure 3 . The control curve, in 143 mM [Na+J (ED50 11 ILM) is comparable with that previously described by Bowery & Brown (1974) (ED50 12.5 Tables 1  and 2. At 3 gM [3H1-GABA, saturable uptake was inhibited by 94% in 2 mM [Nat], 70% in 1 mM (±) nipecotic acid and 35% in 1 mM BABA. Inhibition in 2 mm Na+ solution was constant at substrate concentrations from 0.3 to 100 gM, i.e., over the range in 
Discussion
In these experiments, procedures that reduced the uptake of [3H]-GABA into ganglionic neuroglial cells (reducing external [Na+] to 2 mM, or adding 1 mM ,B-aminobutyric acid (BABA) or (±)-nipecotic acid) strongly potentiated the depolarization of the ganglionic neurones produced by GABA. Available evidence suggests these two effects to be causally related for the following reasons:
(1) The same procedures did not appreciably affect the action of 3-APS. The concentrations of 3-APS used (S1 jIM) are so far below its KT for the GABA carrier (0.8 mM: Bowery, 1974 ) that it could be transported only at a very low rate. (A slight, though significant, augmentation at the lowest concentrations of 3-APS could be detected (see Figure 2) : this is to be expected through the small additive effect of endogenous GABA released during uptake inhibition, Bowery et al., 1976) .
(2) The degree of potentiation showed some relationship to the amount of uptake inhibition produced by the three procedures. Potentiation by BABA is, perhaps, disproportionately great: this could be due to its weak direct agonist activity, which is just around threshold at the concentration used (1 mM: cf. Bowery et al., 1976) : (+)-nipecotic acid appears to Uptake values are corrected for the minor non-saturable infiltration (Bowery et al., 1976) . have no direct agonist activity (N.G. Bowery, personal communication) .
(3) The concentration-sensitivity of low-Na+ effects (Figure 3) follows from the saturable nature of carriermediated transport, such that proportionately less GABA is cleared from the interstitial spaces as the apparent Michaelis constant (KT-7 gM; Bowery & Brown, 1972) is approached or exceeded (the fractional inhibition of uptake in low Na+ being independent of substrate concentration).
Further consideration of the lateral shift in the doseresponse curve in Figure 3 suggests that, at a nominal external GABA concentration of 10;JM in normal (143 mM [Na+] ) solution the effective interstitial concentration is only around 3 ItM, i.e., the steady-state concentration in the tissue is reduced some 70% by the glial transport process. At a nominal external concentration of 3 gM, a larger reduction to 0.6 gM interstitial concentration appears to result. One consequence of this is that the previously-obtained potency measurements, made in normal Na+ solution with a functional carrier (Bowery & Brown, 1974) need revision. In particular, if corrected for the influence of the carrier, GABA becomes equipotent with 3-APS as an agonist, instead of one-third as potent as previously deduced (the potency measurements having been made from the apparent ED50 values).
Thus, the present observations imply that neuroglial cells in sympathetic ganglia are capable of net inward GABA transport at a rate sufficient to reduce the interstitial concentration of GABA. This may have some functional significance, since the concentration of GABA in the plasma has been estimated at 2-4 gM in cats (Crowshaw, Jessup & Ramwell, 1967) .
Inspection of Figure 3 shows that, in the absence of carrier-transport, such a concentration may produce an appreciable depolarization of the ganglion cells, but that carrier-mediated transport can reduce this effect to negligible levels. This would accord with inferences to be drawn from measurements of labelled GABA influx, which appears to drive towards a steady-state intracellular/extracellular concentration gradient of around 103. At a resting intracellular concentration of some 0.5-1 mM (cf. Bowery et al., 1976; Bertilsson, Suria & Costa, 1976) , the glial cells would tend to 'buffer' interstitial GABA to about 1 gM, sufficient to preclude untoward effects on neuronal excitability (cf. Adams & Brown, 1975) . The same considerations might well apply to other peripheral neurones sensitive to GABA, such as autonomic and somatic sensory neurones (De Groat, 1972; De Groat, Lalley & Saum, 1972) , which are also invested by GABA-transporting neuroglial cells (Bowery & Brown, 1972; Young et al., 1973; Schon & Ke; ly, 1974) .
Recently, Curtis, Game & Lodge (1976) have found that inhibitors of GABA transport in the brain (nipecotic acid, L-2,4-diaminobutyric acid and 2,2-dimethyl-f-alanine) applied by iontophoresis to a variety of central neurones potentiated the inhibitory effect of iontophoretically-applied GABA, thus indicating a role for membrane transport in reducing extracellular GABA levels in the central nervous system. At this site clearance may be affected through transport into either neurones or glial cells or both. As the authors point out, their experiments did not clearly indicate the relative importance of neural and glial transport processes, but the effect of the fl-alanine derivative suggests at least a partial role of glial transport (cf. Johnston & Stephanson, 1976) . The present experiments, on a tissue without a neural carrier, support this inference.
